Drug Trial Radar · NCT07519395
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
420
Planned (sponsor's estimate)
Start
Apr 8, 2026
Primary completion
Mar 9, 2027
Study completion Jul 13, 2027
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Apr 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.
Conditions
- Irritable Bowel Syndrome
Interventions
PlaceboDrug
Placebo to be administered
CamlipixantDrug
Camlipixant to be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Weekly Abdominal pain intensity (API) over Weeks 7 to 12Time frame: Baseline, Weeks 7 to 12 (time - average)
Locations
114 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Anniston, Alabama · Recruiting
GSK Investigational Site
Guntersville, Alabama · Recruiting
GSK Investigational Site
Mobile, Alabama · Recruiting
GSK Investigational Site
Saraland, Alabama · Recruiting
GSK Investigational Site
Phoenix, Arizona · Recruiting
GSK Investigational Site
Scottsdale, Arizona · Recruiting
GSK Investigational Site
Tempe, Arizona · Recruiting
GSK Investigational Site
Tucson, Arizona · Recruiting
GSK Investigational Site
Anaheim, California · Recruiting
GSK Investigational Site
Chula Vista, California · Recruiting
GSK Investigational Site
Coronado, California · Recruiting
GSK Investigational Site
Garden Grove, California · Recruiting
GSK Investigational Site
Lancaster, California · Recruiting
GSK Investigational Site
Lancaster, California · Recruiting
GSK Investigational Site
Los Angeles, California · Recruiting
GSK Investigational Site
Murrieta, California · Recruiting
GSK Investigational Site
Pasadena, California · Recruiting
GSK Investigational Site
San Diego, California · Recruiting
GSK Investigational Site
San Diego, California · Recruiting
GSK Investigational Site
Sherman Oaks, California · Recruiting
GSK Investigational Site
West Hills, California · Recruiting
GSK Investigational Site
Aurora, Colorado · Recruiting
GSK Investigational Site
Colorado Springs, Colorado · Recruiting
GSK Investigational Site
Lone Tree, Colorado · Recruiting
GSK Investigational Site
Brandon, Florida · Recruiting
GSK Investigational Site
Clearwater, Florida · Recruiting
GSK Investigational Site
Coral Gables, Florida · Recruiting
GSK Investigational Site
Doral, Florida · Recruiting
GSK Investigational Site
Hialeah, Florida · Recruiting
GSK Investigational Site
Homestead, Florida · Recruiting
GSK Investigational Site
Jacksonville, Florida · Recruiting
GSK Investigational Site
Kissimmee, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
Showing 40 of 114 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.